ICER Seeks Public Comment on Scoping Document for CAR-T Treatments – AJMC.com Managed Markets Network
|
ICER Seeks Public Comment on Scoping Document for CAR–T Treatments
AJMC.com Managed Markets Network CAR–T cells are being considered the next frontier of cell-based immunotherapy to move from the bench to the bedside. By modifying a patient's own T cells, CAR-T treatments transduce the patient's T cells to express a cell surface receptor that can … |
